Colon cancer is a malignant neoplasm arising in the colon and is commonly discussed within the broader colorectal cancer spectrum. It develops from cells in the large bowel and represents the largest subgroup of colorectal cancers.
A study in stage 3 dMMR colon cancer found that atezolizumab plus chemotherapy after surgery cut recurrence and death risk by 50%. The trial enrolled 712 patients and the regimen is now included in treatment guidelines.
Karmanos and the Detroit Public Library have opened registration for the 2026 Community Conversations on Cancer series. Three sessions will address colon cancer, implicit bias in care, and multiple myeloma.
Wafik S. El-Deiry highlighted p53 research and the August 2025 approval of dordaviprone/modeyso, the first treatment for diffuse gliomas with H3K27M mutations. Separate posts also described glioblastoma precision oncology discussions and a lifetime achievement award in Mumbai.
A novel therapeutic vaccine using structural nanomedicine principles has shown promising results against HPV-driven cancers in preclinical models. The spherical nucleic acid vaccine design significantly slowed tumor growth and extended survival by generating potent T-cell responses. Unlike preventive HPV vaccines, this approach is designed to treat established cancers caused by the virus.
Research into Lynch syndrome is advancing cancer prevention through aspirin therapy, vaccine trials, and a major North American study examining why some patients develop cancer while others remain protected.
Colorectal cancer rates are rising 3% annually in adults under 50, prompting expanded screening efforts and new treatment approaches. Recent research shows promise in combination immunotherapy and vaccine strategies for advanced disease.
A nationwide survey reveals 50% of Americans don't know colorectal cancer can be screened at home, as the disease becomes the leading cause of cancer death in adults under 50. Current guidelines recommend screening begin at age 45.
ImmunityBio establishes wholly owned subsidiary in Saudi Arabia to distribute Anktiva for bladder and lung cancer across MENA region, following world's first lung cancer approval in the Kingdom less than a year after May 2025 meeting.
New research demonstrates that physical activity after cancer diagnosis reduces mortality risk in less common cancers and enhances circadian clock function in tumor tissue, supporting exercise as a therapeutic intervention.
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT07596732 |
Statewide Unified Network for Remote Intervention of Strength and Exercise |
NOT_YET_RECRUITING | NA |
| NCT07555639 |
An Integrated Genomic Approach to Assess Genetic Risk and Drug Sensitivity |
ACTIVE_NOT_RECRUITING | NA |
| NCT07546565 |
Mechanical Bowel Preparation in Laparoscopic Right Hemicolectomy With Intracorporeal Anastomosis |
RECRUITING | NA |
| NCT07534852 |
NIMA-Colon Cancer Study |
RECRUITING | NA |
| NCT07510932 |
Fruquintinib In Patients With Metastatic Colorectal Cancer Refractory to Standard Chemotherapies in South Korea Patients (FIRST-K) |
NOT_YET_RECRUITING | PHASE2 |
| NCT07494201 |
MIMICC Study in Patients With Colorectal Cancer |
RECRUITING | NA |
| NCT07436312 |
Impact of Consumption of Ultra-processed Foods in Individuals at High Risk of Cancer |
RECRUITING | NA |
| NCT07432399 |
Effect of Perioperative Lidocaine or High-Dose Dexamethasone on Immune Response in Colon Cancer Surgery (PILDI Study) |
RECRUITING | PHASE2 |
| NCT07428239 |
Pilot Study of Individualized Comprehensive Rehabilitation in Patients With Colorectal Cancer |
COMPLETED | NA |
| NCT07427901 |
Quality Of Life In Colorectal Cancer Survivors |
RECRUITING | NA |
